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Exposure to occupational and environmental contaminants is a major contributor to human
health problems. Inhalation of gases, vapors, aerosols, and mixtures of these can cause a wide
range of adverse health effects, ranging from simple irritation to systemic diseases. Despite
significant achievements in the risk assessment of chemicals, the toxicological database, partic-
ularly for industrial chemicals, remains limited. Considering there are approximately 80,000
chemicals in commerce, and an extremely large number of chemical mixtures, in vivo testing
of this large number is unachievable from both economical and practical perspectives. While
in vitro methods are capable of rapidly providing toxicity information, regulatory agencies in
general are still cautious about the replacement of whole-animal methods with new in vitro
techniques. Although studying the toxic effects of inhaled chemicals is a complex subject, re-
cent studies demonstrate that in vitro methods may have significant potential for assessing the
toxicity of airborne contaminants. In this review, current toxicity test methods for risk evalua-
tion of industrial chemicals and airborne contaminants are presented. To evaluate the potential
applications of in vitro methods for studying respiratory toxicity, more recent models developed
for toxicity testing of airborne contaminants are discussed.
Exposure to occupational and environmental contaminants
is a major contributor to human health problems that can cause
adverse effects ranging from simple irritation to morbidity and
mortality due to acute intense or long-term, low-level repeated
exposures (Klaassen, 2001; Greenberg et al., 2003; Winder
& Stacey, 2004). Inhalation exposures can occur with gases,
vapours, solid and liquid aerosols and mixtures of these. While
evaluating the impact of chemicals on human health requires tox-
icity data, in many cases, particularly for industrial chemicals,
the availability of toxicity information is quite limited (NTP,
1984; Agrawal & Winder, 1996; U.S. EPA, 1998; Faustman &
Omenn, 2001; Marchant, 2005). The current approach of mea-
suring the toxic effects of workplace contaminants relies on
whole-animal test methods. As well as ethical concerns, heavy
reliance on animal data in toxicology is the subject of debate
and controversy by the scientific community (Blaaboer, 2002).
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Moreover, increasing the number of available industrial chemi-
cals and new products has created a demand for alternatives to
animal methods for better safety evaluation. Although studying
the toxic effects of inhaled chemicals is technically more chal-
lenging, the potential application of in vitro methods to study the
toxicity of airborne contaminants needs to be taken into consid-
eration. In this review, methods available for investigating the
toxic effects of industrial chemicals and airborne contaminants
are addressed with a focus on the development, validation, and
potential applications of in vitro test systems. Moreover, the
more recent in vitro models for studying the toxic effects of
inhaled chemicals are reviewed.
AIRBORNE CONTAMINANTS
Air contaminants are exogenous substances in indoor or out-
door air, including both particulates and gaseous contaminants
that may cause adverse health effects in human or animals, affect
plant life, and impact the global environment by changing the
atmosphere of the earth (Raabe, 1999). Various physical, chem-
ical, and dynamic processes may generate air pollution leading
to emission of gases, particulates, or mixtures of these into the
atmosphere (Lioy & Zhang, 1999). While great attempts have
been made to reduce emissions from both stationary and mobile
sources, millions of people today face excessive air pollution in
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both occupational and urban environments (Costa, 2001). Many
industrial and commercial activities release toxic contaminants
in gas, vapor, or particulate forms. Occupational and environ-
mental health problems can potentially arise where such releases
are not controlled properly. Moreover, today air contaminants
are not limited to the urban environment or to the workplace
but are also common indoor air contaminants present in office
workplaces, schools, and hospitals.
TARGET ORGAN: RESPIRATORY SYSTEM
The major physiological function of the respiratory tract is the
transfer of oxygen to the blood and removal of carbon dioxide as
a metabolic waste. The human respiratory tract is ideally struc-
tured to achieve this function, given its very large surface area of
approximately 140 m2 and high daily exchange volume of more
than 10 m3 (Beckett, 1999; Boulet & Bowie, 1999; Hext, 2000;
Witschi & Last, 2001). In addition, the membrane between air
and blood in the gas exchange region is extremely thin, approx-
imately 0.4–2.5 µm (Brouder & Tardif, 1998; Winder, 2004a).
As well as olfactory, gas exchange, and blood oxygenation func-
tions, the respiratory system has evolved to deal with xenobi-
otics and airborne materials such as those usually occurring in
the air environment (Lambre et al., 1996). However, this system
cannot always deal adequately with the wide range of airborne
contaminants that may occur in urban and particularly occupa-
tional environments (Winder, 2004a). As a result, the respiratory
system is both a site of toxicity for pulmonary toxicants, and a
pathway for inhaled chemicals to reach other organs distant from
the lungs and elicit their toxic effects at these extrapulmonary
sites.
Responses to inhaled toxicants range from immediate re-
actions to long-term chronic effects, from specific impacts on
single tissue to generalized systemic effects (David & Wagner,
1998; Winder, 2004b). The severity of toxic effects of inhaled
chemicals is influenced by several factors such as type of air
contaminant, airborne concentration, size of airborne chemi-
cal (for particles), solubility in tissue fluids, reactivity with tis-
sue compounds, blood-gas partition coefficient (for gases and
vapors), frequency and duration of exposure, interactions with
other air toxicants, and individual immunological status (David
& Wagner, 1998; Rozman & Klaassen, 2001; Winder, 2004b).
The site of deposition/action of inhaled toxicants will determine,
to a great extent, the ultimate response of the respiratory tract
to inhaled chemicals. After inhalation, airborne contaminants
may be deposited in different regions of the respiratory tract,
including nasopharyngeal, tracheobronchial, and pulmonary
regions.
DEPOSITION OF AIRBORNE CONTAMINANTS
IN THE RESPIRATORY TRACT
Apart from the physiological and anatomical characteristics
of the respiratory tract, physicochemical and aerodynamic char-
acteristics of inhaled chemicals are crucial in determining the
site of deposition/absorption and the ultimate fate of inhaled
contaminants.
Gases and Vapors
Water solubility is the significant factor that determines the
penetration site of a gas in the respiratory tract. For example
ammonia, formaldehyde, sulfur dioxide, and hydrogen fluoride
are extremely soluble in water and tend to be absorbed nearly
completely within the nose and upper airways. While the nose
acts as a scrubber for water-soluble gases to protect the lungs
from potential toxic effects, the drawback of this protective ac-
tion is the probability of production of toxic effects in the nose
such as formaldehyde, which may induce nasal cancer (Rozman
& Klaassen, 2001; IARC, 2004). Gases with low solubility, such
as nitrogen dioxide, ozone, and phosgene, penetrate further into
the pulmonary region and exert their toxicity in this region. Ul-
timately, very insoluble gases such as carbon monoxide and hy-
drogen sulfide pass through the respiratory tract efficiently and
are delivered throughout the body through the pulmonary blood
supply system. Although water solubility is a critical parame-
ter in penetration of gaseous contaminants, other factors such
as partition coefficient may also have a considerable influence.
For example, when a gas penetrates to the gas-exchange region,
the blood-gas partition coefficient will determine the rate of gas
uptake into the blood (Hext, 2000; Rozman & Klassen, 2001).
Aerosols
Particle size distribution is the most critical characteristic that
determines airborne behavior and deposition pattern of aerosols
in the respiratory tract (Asgharian et al., 1995). Airborne par-
ticles usually are polydispersoid with an approximately log-
normal size distribution. During inhalation, a specific volume
of air from the breathing zone accelerates towards the nose (or
mouth) and enters into the respiratory tract. As well as air, par-
ticles with specific median cut-point of aerodynamic diameter
(d50) that can follow the airstream will enter into the respira-
tory tract. Larger particles usually are deposited in the nasopha-
ryngeal region by an inertial impaction mechanism (inhalable
fraction, d50 = 100 µm). Aerosols that fail to be captured in the
nasopharyngeal region will be deposited in the tracheobronchial
region (thoracic fraction, d50 = 10 µm) and may be absorbed or
be cleaned by mucociliary clearance. Finally, the remaining par-
ticles with the smallest size distribution that are not trapped in
the tracheobronchial region will penetrate deeply into the alve-
olar region (respirable fraction, d50 = 4 µm) of the respiratory
tract and diffuse to respiratory tissues (ACGIH, 2001).
TOXICITY ASSESSMENT APPROACHES
While data obtained from human experiences would be most
useful in assessing the toxic effects of chemicals, human data is
not always available for developing safety evaluations on chem-
icals and airborne contaminants. Moreover, because of unfor-
tunate human experiences such as those with pharmaceutical
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agents like diethylstilbestrol and thalidomide, or occupational
and environmental contaminants like lead and polychlorinated
biphenyls (PCBs), it is now understood that the risks of chemi-
cals, new products, and technologies need to be assessed before
adverse human experiences occur (McClellan, 1999; Thorne,
2001; Greenberg & Philips, 2003). Therefore, as part of pre-
ventive strategies, it is critical to develop new approaches that
are both informative and time/cost efficient to identify the po-
tential hazards in the absence of widespread human exposures
(Silbergeld, 1998). In general, no single method can cover the
complexity of general toxicity in humans (Barile, 1994). How-
ever, toxicity data can be obtained from several sources, includ-
ing toxicological studies, epidemiological studies, quantitative
structure–activity relationships (QSARs), and physiologically
based toxicokinetic (PBTK) studies.
Toxicology has made a major contribution in providing chem-
ical toxicity information for many years. Today, toxicology con-
tinues to develop by the application of the risk assessment pro-
cess as a systemic, scientific approach for characterizing and
quantifying potential adverse effects of chemicals (Faustman
& Omenn, 2001). Moreover, in vitro toxicology methods, us-
ing cell culture technology in combination with knowledge of
structure–activity relationships and toxicokinetics, are currently
being developed and implemented in modern toxicology. From
a methodology perspective, toxicological test methods ranging
from conventional whole animals usage (in vivo) to modern cell
culture (in vitro) techniques.
In Vivo Toxicity Test Methods
Conventional methods of toxicological assessment are based
on whole-animal studies. A basic assumption of in vivo or ani-
mal toxicity studies is: Chemicals that cause adverse effects in
animals can cause such effects in humans as well. Thus, data
obtained from animals can be extrapolated to humans by a vari-
ety of techniques. Animal toxicity studies began in 1927 when
the LD50 test was introduced by Trevan in the United States
(Trevan, 1927). As the LD50 can provide essential information
on the toxic effects of chemicals, this test usually is performed
on a new chemical in order to identify acute oral toxicity. The
process involves the feeding to animals of a test chemical at in-
creasing doses until the dose that is capable for killing 50% of
test animals is determined (OECD, 2001a). It is necessary that
the LD50 values indicate the route of exposure (oral or dermal),
the animal species used in the test, and the unit of measurement
of dose (usually mg/kg body weight) (Cote et al., 1998).
Acute toxicity data are usually applied to toxicity classifica-
tion and labeling requirements for risk assessment of chemical
substances. More recently, a globally harmonized system (GHS)
of classification has been proposed for physicochemical, single-
or repeated-dose toxicity and environmental toxicity endpoints
(United Nations [UN], 2003). In this classification, criteria have
been developed for a range of different single dose toxicity end-
points. Based on acute toxicity by the oral, dermal and inhala-
tion route, chemicals include one of five escalating toxicity cate-
gories according to the numeric criteria expressed as LD50 (oral,
dermal) or LC50 (inhalation) values (OECD, 2001b; UN, 2003).
It is anticipated that when implemented the GHS will enhance
the protection of human health and the environment under a
globally harmonized system of classification.
In recent years, conventional animal toxicity tests, particu-
larly tests such as the LD50, are criticized on ethical grounds by
animal welfare groups due to the possible use of large numbers of
animals and the suffering such tests can cause. Hence the Organi-
zation for Economic and Cooperative Development (OECD) has
developed three alternative tests for acute oral toxicity, the Fixed
Dose Procedure (420), the Acute Toxic Class Method (423), and
the Up and Down Procedure (425), to modify the conventional
acute oral toxicity test (401) in order to reduce the number of
animals used per test substance (OECD, 2001a). Besides these
ethical concerns, heavy reliance on animal data in toxicology has
long been a concern of the scientific community. Prediction of
biological activities of toxic compounds in humans with reliance
on animal data always poses some degree of uncertainty due to
interspecies differences between animals and humans (O’Hare
& Atterwill, 1995; Gad, 2000; Blaaboer, 2002). Even within a
species, great interindividual variation may occur due to more
subtle genetic variations (intraspecies differences), (Faustman
& Omenn, 2001). Moreover, the validity of extrapolation from
high doses/concentrations to real-world low-level exposures is
being questioned, particularly when such extrapolations are not
supported by mechanistic information (Eisenbrand et al., 2002).
Although the magnitude of a toxic effect is usually propor-
tional to the exposure level, the biological differences between
high- and low-dose scenarios needs to be considered (Benford
et al., 2000). Toxicologists have traditionally attempted to over-
come these uncertainties by introducing uncertainty factors in
establishing safety standards for human exposures (Faustman &
Omenn, 2001; Eisenbrand et al., 2002).
Respiratory Toxicity Study in vivo
Extensive background data have been developed from toxi-
cological studies using animal models. However, most of these
studies are conducted by oral and dermal exposures rather than
inhalation exposure (Agrawal & Winder, 1996; Miller & Klonne,
1997). While toxicology data may exist from other routes of
exposure, the extrapolation of these data is most difficult to val-
idate. In order to identify the lethal effects of air toxicants, in-
halation toxicity tests need to be carried out in test animals. Test
animals are exposed to air toxicants dissolved or suspended in
air, contaminated air is inhaled, and the concentration that causes
lethality in 50% of dosed group (LC50) is determined. In re-
porting an LC50, both the concentration of the chemical in air
that can cause death in 50% of exposed animals and the time
of exposure should be indicated. Standard protocols have been
adopted by regulatory agencies for both short-term and long-
term inhalation tests. The OECD has initially adopted guide-
lines for acute inhalation toxicity (403), repeated-dose inhalation
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toxicity 28/14-day (412), and subchronic inhalation toxicity
90-day (413). Meanwhile, new guidelines for acute inhalation
toxicity, such as the Acute Inhalation Toxicity-Fixed Dose Pro-
cedure (433) and Acute Inhalation Toxicity-Acute Toxic Class
(ATC) Method (436), are being finalized (OECD, 2004).
In inhalation studies, evaluating the dose received by the an-
imal is more challenging due to several factors that influence
the actual dose, such as atmospheric concentration, duration of
exposure, pulmonary physiological characteristics of the test an-
imal, and deposition/absorption patterns of the air contaminant.
In a specified system for many inhaled chemicals the actual dose
is related to the product of concentration (c) and exposure time
(t), which is known as Harber’s law (c × t = inhaled dose)
(Hext, 2000; Valentine & Kennedy, 2001). In many cases, par-
ticularly in short-time exposures to chemicals with direct action
on the respiratory system, the response is directly proportional
to the product of c × t. However, many other substances, such as
chemicals that exhibit systemic toxicity, do not follow Harber’s
law because in such cases several factors, including absorption
by the respiratory tract, tissue distribution, biotransformation in
potential target organs, and elimination, will influence the toxi-
city (Hext, 2000). Although Harber’s law does not apply to all
chemicals, it can be applied when extrapolated to c × t values
that differ by a factor of about 3 to 4 for a given c × t product
(Valentine & Kennedy, 2001).
The selection of an animal species for toxicity studies is an-
other crucial consideration that may influence the outcome of
in vivo studies and the estimated human adverse health effects.
Usually rodents such as rat, mouse, guinea pig, and hamster are
used. However, different criteria should be considered in the
selection of animals, such as species-related physiological fac-
tors, the size of the animals, the availability of the animals, the
number of animals needed, the cost of obtaining and maintaining
required number of animals, and the cost of producing consistent
atmospheric test concentrations (Valentine & Kennedy, 2001).
Generation and characterization of known concentrations of
air contaminants and reproducible exposure conditions is a more
complicated and expensive procedure than that required for oral
and dermal exposures. This process requires different equipment
and techniques to generate, maintain and measure standard test
atmospheres. Inhalation exposure systems involve several effi-
cient and precise subsystems, including a conditioned air supply
system, a suitable gas or aerosol generator for test chemical, an
atmosphere dilution and delivery system, an exposure chamber,
a real-time monitoring or sampling and analytical system, and
an exhaust/filter or scrubbing system (Phalen, 1997; Hext, 2000;
Valentine & Kennedy, 2001).
The more common exposure modes to evaluate the effect
of inhaled air toxicants involve whole-body, head-only, and
nose-only. Whole-body exposure mode is conducted most fre-
quently for human inhalation studies. Head-only exposure mode
is suitable for repeated short-time exposure for restricting the
portal of entry of the test chemical to the respiratory system.
Design and construction of head-only units are similar to those
of nose-only units. Nose-only exposure units require an ani-
mal holder to accommodate rodents with suitable size to reduce
stress and discomfort. The animal holder is normally designed
to fit the general shape of the animal, with a conical head-
piece using polymethyl methacrylate, polycarbonate, or stain-
less steel. The animal holder is connected to the exposure cham-
ber that introduces the test chemical into the face or nose of the
animal.
Exposure chambers can be operated in both static and dy-
namic systems. Usually animal inhalation toxicity studies are
carried out in a dynamic system to avoid particle settling and ex-
haled gas complications. While the operation of a static system
is relatively simple and requires comparatively less test material,
this is only suitable for short exposure times due to reliance on
the air inside the chamber. In contrast, in a dynamic system, the
test atmosphere flows through the exposure chamber continu-
ously and hence ensures atmospheric stability and no reduction
in oxygen concentration due to test animal respiration (Hext,
2000). This system requires accurate flow monitoring for both
diluent air and primary source of contaminant in proportions
that can produce the final desired concentrations.
In Vitro Toxicity Test Methods
The focus of toxicology has shifted somewhat, since the mid
1980s, from whole-animal toxicity tests to alternative in vitro
toxicity methods (Silbergeld, 1998; Gad, 2000). Basic cell cul-
ture techniques are designed to provide a proper support of cells
or tissues for their normal survival, growth, and function in vit-
reous media (formerly glass and more recently plastic) outside
the body. Application of cell culture techniques in toxicologi-
cal studies is referred to as in vitro toxicology, which describes
a field of study that applies technology using isolated organs,
tissues, and cell culture to study the toxic effects of chemicals
(Hayes & Markovic, 1999). Since the first mammalian cells were
grown in capillary glass tubes in the United States, cell culture
technology, and hence in vitro toxicology, has progressed and
during the last two decades gained an increasing acceptance in
toxicological investigations (Barile, 1994; Gad, 2000). As well
as scientific advances, the development of in vitro toxicity test
methods has been influenced by a variety of socioeconomical
factors.
Historical Perspective
The concept of alternatives, which is considered as the devel-
opment of test systems other than those relying on whole ani-
mals, was started with the contribution of two British scientists,
W. M. S. Russel and R. L. Burch, by the introduction of the three
Rs in their book The Principles of Humane Experimental Tech-
niques in 1959. The three Rs provide the conceptual basis for
reconsideration of using animals in research and refer to reduc-
tion in the number of test animals, refinement of test protocols
in order to minimize suffering of test animals, and replacement
of current animal tests with appropriate in vitro tests. Initially,
the principles introduced by Russel and Burch did not receive
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attention until the growth of the animal welfare movement in the
mid 1970s (Reinhardt, 1994; Silbergeld, 1998).
However, the development of in vitro test systems has been in-
fluenced by a number of factors (Purchase et al., 1998). Animal
welfare issues are among the most important social concerns
that have impacted on the recent shift toward alternatives in
toxicity testing. Animal rights activities and increasing public
awareness of certain animal testing requirements have forced
researchers and regulatory agencies to increase and diversify
the development and validation of alternative methods. Another
social issue is the increasing public interest on the safety of
chemicals and new products. Each year, thousands of new cos-
metics, pharmaceuticals, pesticides, and consumer products are
introduced into the marketplace. Considering there are approx-
imately 80,000 chemicals in commerce (NTP, 2001), as well as
the extremely large number of chemical mixtures, in vivo testing
of these numbers of chemicals requires a large number of ex-
pensive, time-consuming, and in some cases nonhumane tests in
animal species. The necessity of determination of the potential
toxic effects of this large number of chemicals has provoked the
need for rapid, sensitive, and specific test methods.
Applications of In Vitro Toxicity Methods
In vitro toxicity methods were first developed to study the
mechanisms of actions of chemical substances at molecular and
cellular level (Frazier, 1992). Increasingly, in vitro methods have
been applied in many fields such as cancer biology, drug discov-
ery, and toxicology. Genotoxicity was the first field of toxicology
in which in vitro test methods have been used for toxicity test-
ing to identify the mutagenic characteristics of chemicals (Ames
et al., 1973, 1975). At present, in vitro methods cover a broad
range of techniques and models, and a standardized battery of in
vitro tests can be used for assessing acute local and systemic tox-
icity. Cytotoxicity testing, reproductive toxicity, mutagenicity,
irritancy testing, immunology, and target organ toxicity are the
main areas of in vitro toxicology (O’Hare & Atterwill, 1995).
Meanwhile, the application of in vitro methods in toxicol-
ogy is also being faced by a number of difficulties. One impor-
tant shortcoming of in vitro methods is the lack of complexity
(Zucco et al., 1998). While cells in culture represent the ele-
mentary living systems, as a very simplified system, they cannot
represent the complexity of the entire organism. An in vitro
system cannot replicate exactly the biodynamics of the whole
human body due to the lack of possible mitigating systems (such
as hormones, nervous system, and immunity), and the lack of
biotransformation and excretion pathways for their elimination
in vitro (Hayes & Markovic, 2002). The challenge of how to
relate concentrations that produce cellular toxicity in vitro to
equivalent in vivo dosages may be improved by the develop-
ment and application of predictive tools such as physiologically
based toxicokinetic (PBTK) models (Frazier, 1992). The basic
toxicology knowledge of absorption, distribution, metabolism,
and elimination (ADME) of chemicals is essential for the de-
velopment of appropriate toxicokinetic models. The next lim-
itation of these methods is related to chronic toxicity testing.
Although some studies are promising (Scheers et al., 2001), to
date, in vitro test systems are mainly focused on acute toxicity
testing rather than short-term or long-term repeated dose toxicity
investigations (Eisenbrand et al., 2002). More knowledge of the
mechanisms of toxicity is still needed before in vitro methods
could broadly be implemented for repeated dose toxicity testing
(Lambre et al., 1996). Physicochemical properties of test chem-
icals such as low water solubility or high vapor pressure may
also cause technical problems during the course of in vitro tests
(Stark et al., 1986; Frazier & Bradlaw, 1989; Ciapetti, 1998).
Nevertheless, in vitro toxicity test systems offer new advan-
tages when compared to traditional in vivo toxicity methods
(Balls & Fentem, 1992; Frazier, 1992; Anderson & Russell,
1995; Zucco et al., 1998, 2004; Eisenbrand et al., 2002; Holme
& Dybing, 2002). In vitro test methods eliminate the inter-
species extrapolation by using human cells and tissues, which
may assist to generate more representative data for human tox-
icological risk assessments. These methods are comparatively
simpler, faster, and hence less time-consuming and more cost-
efficient (Anderson & Russel, 1995). They facilitate the applica-
tion of biochemical, cellular, and molecular biology techniques
to study the underlying mechanism of toxic action (Blaauboer,
2002; Holme & Dybing, 2002). In vitro models for organ tox-
icity evaluation developed for many organs and tissues (such
as nephrotoxic, neurotoxic, and hematotoxic models) allow the
study of components of potential target organs and target sys-
tems (Zucco et al., 2004). Despite the complex organization of
cells, in vitro methods are also developed for respiratory toxic-
ity assessment using relevant airway cells, lung cells, or tissues
and implementation of target specific endpoints (Lambre et al.,
1996; ICCVAM, 2001).
Considering these advantages, in vitro toxicology is one of
the most rapidly expanding areas of alternative methods with
many practical applications (Barile, 1994; Faustman & Omenn,
2001; Eisenbrand et al., 2002). In vitro toxicity methods can be
used for screening, ranking, and risk assessment of chemicals
and new products. These methods can be applied to determine
the adverse effects of industrial chemicals, pharmaceuticals, and
consumer products that are being manufactured and marketed
at rapid and extraordinary rates (Barile, 1997). Many of these
products have never been adequately tested, mainly due to the
cost of animal tests (Marchant, 2005). Further, these chemical
entities are formulated into hundreds of thousands of chemical
products, where not only is the toxicity of individual ingredients
poorly understood, but the potential toxic interactions between
individual chemicals in such mixtures are unpredicted (Yang,
1994). The potential toxic interactions of chemical mixtures can
be assessed using in vitro test methods (Malich et al., 1998;
Cross et al., 2001).
Mechanistic information provided by in vitro toxicity
methods has both theoretical and practical applications. Such
information can supply a scientific base for interpretation of de-
scriptive toxicity data and assessment of the possibility that a
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chemical will induce adverse effects if those effects occur at
the molecular or cellular level. Mechanistic approaches may fa-
cilitate to explore procedures to prevent or antagonize toxicity,
formulate new drugs and industrial products that are less harm-
ful, and design pesticides that are more selectively toxic for
their target organisms (Silbergeld, 1998; Faustman & Omenn,
2001). For example, the application of pharmacogenetics and
pharmacogenomics in the drug development process may not
only improve the safety and efficacy of new drugs but also im-
prove the development of optimal dosing regimens (Lesko et al.,
2003). In addition, in vitro methods can be applied as biomarkers
of chemical hazards such as biomonitoring of food, water, and
air for environmental and occupational toxicants (Barile, 1994;
Eisenbrand et al., 2002). In occupational and environmental tox-
icology biomarkers have a potential to be used as a predictive
tool via biomonitoring of the causal pathway between exposure
and effect. This pathway may be illuminated by intelligent appli-
cation of new molecular biology technologies such as genomics
(DNA sequences) and proteomics (protein expression) (Benford
et al., 2000).
In Vitro Toxicity Endpoints
Different levels of organization in the human body may be
affected by chemical substances from molecules to cell to tis-
sue to organ to functional levels. Cytotoxicity is the adverse ef-
fects that occur from the interaction of a toxicant with structures
and/or processes essential for cell survival, proliferation, and/or
function (Ekwall, 1983). Toxic chemicals can attack any of the
basal cell functions, origin-specific cell functions, and extracel-
lular functions. To assess the potential cytotoxicity of chemical
substances, several in vitro tests have been developed by mea-
suring different biological endpoints, which are summarized in
Table 1 (Balls & Clothier, 1992; Barile, 1994, 1997; Anderson
& Russell, 1995; Zucco et al., 1998; Doyle & Griffiths, 2000;
Freshney, 2000; Wilson, 2000). In addition, over recent years,
research on apoptosis has enormously changed the knowledge
of mechanisms involved in cell death, leading to the develop-
ment of mechanistically based endpoints. Many morphological
and biological changes that may occur at the cellular membrane,
nucleus, specific proteases, and DNA level can be used as bio-
logical endpoints for measuring apoptosis (Wilson, 2000; Zucco
et al., 2004). Moreover, the rapid progress in genomic, tran-
scriptomic (gene expression), and proteomic technologies has
created a unique powerful tool in toxicological investigations
(Eisenbrand et al., 2002).
Validation of In Vitro Test Methods
Currently, in vitro toxicity methods have gained different val-
ues with regard to reliability and acceptance. While some pro-
cedures may be directly substituted in place of existing animal
models, many other procedures are used for screening or in ad-
junct tests (Reinhardt, 1994; Gad, 2000). For instance, one of
the longest standing validated and regulatory accepted alterna-
TABLE 1
Common biological endpoints assessed by in vitro toxicity tests
Biological endpoint Detection method
Cell morphology Cell size and shape
Cell–cell contacts
Nuclear number, size, shape, and
inclusions
Nuclear or cytoplasmic vacuolation
Cell viability Trypan blue dye exclusion
Diacetyl fluorescein uptake
Cell counting
Replating efficiency
Cell metabolism Mitochondrial integrity (MTT, MTS, and
XTT tetrazolium salt assays)
Lysosome and Golgi body activity
(neutral red uptake)
Cofactor depletion (e.g. ATP content)
Membrane leakage Loss of enzymes (e.g., LDH), ions or
cofactors (e.g., Ca2+, K+, NADPH)
Leakage of prelabeled markers (e.g., 51Cr
or fluorescein)
Cell proliferation Cell counting
Total protein content (e.g., methylene
blue, Coomassie blue, Kenacid blue)
DNA content (e.g., Hoechst 33342)
Colony formation
Cell adhesion Attachment to culture surface
Detachment from culture surface
Cell–cell adhesion
Radioisotope Thymidine incorporation into DNA
incorporation Uridine incorporation into RNA
Amino acids incorporation into proteins
tives is the Limulus amebocyte lysate (LAL) test for detection of
pyrogenic endotoxins in pharmaceutical products as a replace-
ment to the rabbit pyrogen test (Liebsch, 1995). In addition,
presently, a few well-defined instances such as skin corrosivity
(OECD in vitro skin corrosion tests; 430 and 431) and pho-
totoxicity (OECD in vitro 3T3 NRU phototoxicity test; 432)
tests have successfully been validated and accepted for regula-
tory purposes (Spielmann et al., 1998; Spielmann & Liebsch,
2001; Carere et al., 2002; Indans, 2002; Liebsch & Spielmann,
2002). A number of prevalidation studies for regulatory pur-
poses are currently in progress by the European Centre for
Validation of Alternative Methods (ECVAM), such as neurotox-
icity, nephrotoxicity, and carcinogenicity testing (Carere et al.,
2002). Development and validation of new alternative meth-
ods that offer additional or more accurate toxicity informa-
tion can strengthen the science base and hence persuade their
adoption by regulatory authorities (NTP, 2001). Although tradi-
tional animal test methods are unlikely to be eliminated and
substituted at present, every effort should be encouraged to
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develop and validate alternative test systems. As Professor Balls
(2004) predicted, changes will occur but not rapidly: “Progress
will be made only if both time and money are invested in the
search for alternatives. Changes will occur step by step, with
each step being carefully evaluated before it is accepted and im-
plemented. Unfortunately, there are no instantaneous solutions”
(p. 167).
The current status of in vitro methods for assessing acute
toxicity has been reviewed in a workshop organized by the U.S.
Interagency Coordinating Committee on the Validation of Alter-
native Methods (ICCVAM), and it has been concluded that while
animals are currently used for the evaluation of acute toxicity,
recent correlation studies demonstrate that in vitro methods may
also have significant potential in prediction of human acute toxi-
city (ICCVAM, 2001; Botham, 2004). Moreover, as the ultimate
goal of toxicity tests is the prediction of toxicity in humans, the
development and validation of human cell-based methods are
preferred. After this evaluation study, a collaborative study on
the use of basal cytotoxicity tests for estimating both rodent
LD50 values and human lethal concentrations has been initiated
by the ICCVAM and ECVAM. In this study, a total 72 refer-
ence chemicals are currently being tested using normal human
keratinocyte (NHK) cells and BALB/c 3T3 fibroblasts in three
different laboratories (Botham, 2004). One outcome of this val-
idation study may be the introduction of in vitro test results in
the field of regulatory toxicology as an alternative to those from
animal studies.
To characterize the current status of the application of in vitro
cytotoxicity assays in the prediction of acute toxicity in vivo,
a number of approaches have been reviewed by the ICCVAM
workshop. The two main approaches included the Multicentre
Evaluation of In Vitro Cytotoxicity (MEIC) and the German Cen-
ter for the Documentation and Validation of Alternative Methods
(ZEBET) approaches (ICCVAM, 2001).
ZEBET approach. The ZEBET approach is proposed by
the German Centre for the Documentation and Validation of
Alternative Methods. In this approach, data from RC (Registry
of Cytotoxicity), which is a database of acute oral LD50 val-
ues from rat and mice taken from the NIOSH Registry of Toxic
Effects of Chemical Substances (RTECS), and 50% inhibitory
concentration (IC50) values of chemicals from in vitro cytotox-
icity assays are used. The RC database contains a regression
analysis of in vitro IC50 values and in vivo rodent LD50 values
for 347 chemicals. Basal cytotoxicity appeared to be an accept-
able predictor of the LD50 for 74% of the RC chemicals (Halle
& Spielmann, 1992; ICCVAM, 2001). Therefore, it is expected
that most chemicals with acute toxicity may reflect an insult to
the basal intrinsic cell functions (Eisenbrand et al., 2002). Based
on the ZEBET proposed strategy, in vitro cytotoxicity data, in
the short term, can be used to predict the starting dose for in vivo
testing in order to reduce the use of animals (Halle & Spielmann,
1992; ICCVAM, 2001).
MEIC program. The MEIC cytotoxicity program, orga-
nized by the Scandinavian Society for Cell Toxicology (SSCT),
was an international research project to investigate the relevance
of in vitro toxicity assays for the prediction of human acute tox-
icity. In this study, carried out between 1989 and 1996, 50 ref-
erence chemicals, selected from different classes of chemicals,
were tested in 97 laboratories using 61 in vitro methods. To pro-
vide a background to the in vitro/in vivo evaluation, rodent LD50
values were correlated with human lethal doses, indicating a rel-
atively good correlation (R2 = .61 and R2 = .65) for the rat and
mouse respectively (Ekwall, 1999). To investigate the relevance
of in vitro findings, IC50 values from in vitro assays were cor-
related with human lethal blood concentrations (LCs) complied
from human poisoning reports. Human cell line assays were de-
termined as the best predictor of human toxicity (R2 = .74)
when compared to animal cell lines (R2 = .64), (Ekwall, 1999).
One important outcome of the MEIC study was that a test bat-
tery of in vitro assays can be used directly to predict human
acute lethal toxicity (Ekwall, 1999). Therefore, once disposi-
tion information (absorption, biotransformation, elimination) is
taken into account, in vitro assays have the potential to be used
as a surrogate for single-dose toxicity, as usually obtained from
LD50 and similar animal toxicity tests. The results of the MEIC
study are provided as a series of papers in Alternative To Labora-
tory Animals (ATLA) Journal, and overviews of the final MEIC
results have also been published (Clemedson & Ekwall, 1999;
Ekwall, 1999).
Respiratory Toxicity Study In Vitro
The study of the toxic effects of inhaled chemicals is typi-
cally more challenging due to the technology required for the
generation and characterization of test atmospheres, and the
development of effective and reproducible techniques for ex-
posure of cell cultures to airborne contaminants. A practical
approach for in vitro respiratory toxicity testing has been pro-
posed by ECVAM (Lambre et al., 1996). This systemic approach
is initiated with the consultation of existing literature, evaluat-
ing the physicochemical characteristics of test chemicals, and
predicting potential toxic effects based on structure–activity re-
lationships (SARs). Physicochemical characteristics of chemi-
cals such as molecular structure, solubility, vapor pressure, pH
sensitivity, electrophilicity, and chemical reactivity are impor-
tant properties that may provide critical information for hazard
identification and toxicity prediction (Gad, 2000; Faustman &
Omenn, 2001).
Initial in vitro tests should be conducted to identify likely
target cells and toxic potency of test chemicals. Based on the
obtained result, in vitro tests may be followed by a second phase
using the following cells: nasal olfactory cells, airway epithelial
cells, type II cells, alveolar macrophages, vascular endothelial
cells, fibroblasts, and mesothelial cells (Lambre et al., 1996).
Moreover, advantages and limitations of using different cell
types and endpoints for toxicity measurement of air contami-
nants have been discussed in this workshop. While more than
10 main cell types have been identified in the epithelium of the
respiratory tract, for the assessment of respiratory toxicity it is
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important to utilize specific cell types with appropriate metab-
olizing activity. Therefore, freshly isolated cells maintained in
suitable culture media that can mimic biotransformation activi-
ties and cellular functions comparable to the in vivo environment
are preferred to long-term cultures or cell lines that may differ-
entiate, lose their organ-specific functions, and lack the enzyme
systems required for biotransformation (Barile, 1994; Lambre
et al., 1996). It has been suggested the endpoints to be used
need to be selected based on the knowledge of toxic effects of
test chemicals and should always include cell viability testing
in at least two different cell types. A better understanding of
mechanisms involved in respiratory toxicity and also the devel-
opment of standardized and reproducible in vitro exposure and
delivery systems that simulate inhalation exposure in vivo were
encouraged by the ECVAM workshop.
The toxic effects of air contaminants have been studied using
several in vitro exposure techniques (Table 2). Most of these,
especially studies conducted on particulates, are limited to ex-
posure of cells to test chemicals solubilized or suspended in cul-
ture medium (Nadeau et al., 1995; Governa et al., 1997; Goegan
et al., 1998; Baeza-Squiban et al., 1999; Becker et al., 2002;
Takano et al., 2002; Riley et al., 2003; Okeson et al., 2004). Al-
though this exposure condition may be adequate for soluble test
materials, this may not follow the in vivo exposure pattern of
TABLE 2
In vitro exposure techniques developed for toxicity study of air
contaminants
Exposure technique Exposure achievement procedure
Exposure to test
chemical itself
Cells are exposed to test chemicals
solubilized or suspended in culture
media
Exposure to collected
air samples
Cells are exposed to suspended or
extracted particulates collected by
filtration technique
Submerged exposure
condition
Test gas is introduced to cell
suspension under submerged
condition using impinger or vacuum
test tubes
Intermittent exposure Cells are periodically exposed to
gaseous compound and culture
medium at regular intervals using
variation of techniques: rocker
platforms, rolling bottles
Continuous direct
exposure
Cells are continuously exposed to
airborne contaminants during the
exposure time, usually on their
apical side, while being nourished
from their basolateral side, using
collagen-coated or porous
membranes permeable to culture
media
airborne aerosols, particularly for insoluble aerosols, due to un-
expected alternation of their compositions and particle–media or
particle–cell interactions (Diabate et al., 2002). Moreover, such
techniques for exposure may often ignore size, which is crucial
in toxicity testing of inhaled particles. Some other researchers
have employed sampling the aerosols on filters followed by the
investigation of the effects of suspended and extracted parti-
cles, such as those studies that have been conducted on atmo-
spheric aerosols (Hamers et al., 2000; Yamaguchi & Yamazaki,
2001; Alfaro Moreno et al., 2002; Glowala et al., 2002; Baulig
et al., 2003) or cigarette smoke condensate (Bombick et al.,
1998a, 1998b; McKarns et al., 2000; Putnam et al., 2002). Fil-
tration offers an advantage for on site toxicity assessments of
aerosols; however, this technique usually requires sample prepa-
ration steps, such as extraction to isolate the components of in-
terest from a sample matrix, and ultimately, solubilization in
culture media, potentially increasing experimental errors and
further toxicity interactions.
Several in vitro models have also been developed to deal with
gas-phase exposure of airborne contaminants using different ex-
posure techniques. Different features of exposure techniques de-
veloped for gaseous compounds have been discussed in terms of
their relevance, advantages, and limitations (Ritter et al., 2001).
In principle, these methods include exposure of cells under sub-
merged conditions, intermittent exposure procedures, and more
recently direct exposure techniques.
A submerged exposure condition can easily be achieved us-
ing variation of laboratory procedures to introduce test gaseous
compounds to cell suspensions. For example, in order to study
the in vitro toxic effects of ozone on human haematic mononu-
cleated cells (HHMC), the test gas was introduced at once to cell
suspensions in vacuum test tubes (Cardile et al., 1995). How-
ever, exposure patterns in vivo may not be closely simulated and
only a very small interface between the test gas and the target
cells can be provided by the submerged exposure technique.
Variation of laboratory techniques have been developed al-
lowing intermittent exposure of cultures to gaseous contam-
inants. Cell culture dishes held on chambers or platforms
rounded, shacked or tilted at certain angles were exposed to
gaseous compounds periodically (Van Der Zee et al., 1987;
Blanquart et al., 1995; Rusznak et al., 1996). Cell culture flasks
were also tilted at regular intervals to expose the cell cultures
to volatile anaesthetics (Muckter et al., 1998). Rolling culture
bottles on roller drums were set up for in vitro gas exposure
(Shiraishi et al., 1986). Lung slices were alternatively fed by
culture medium and exposed to the diesel exhausts by rotating
the culture vial on the internal wall of a flow-through cham-
ber (Morin et al., 1999). Tissue culture flasks on a rocking
platform were used to expose the cells to mainstream cigarette
smoke, followed by an immersion in culture media intermittently
(Bombick et al., 1998c). Compared to submerged exposure, the
intermittent exposure technique provides a larger interface be-
tween gaseous compound and target cells. Nevertheless, in such
exposure conditions cells are always covered by an intervening
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layer of medium that may influence both accuracy and repro-
ducibility of the results.
More recently, technology has become available that allows
cells to be cultured on permeable porous membranes in transwell
or snapwell inserts (Suppliers; Costar, Falcon and Nunc). Once
cells are established on the membrane, the upper layer of culture
media can be removed, and the cells are directly exposed to air
contaminants. In a direct exposure technique at the air/liquid
interface target cells can be exposed to airborne contaminants
continuously during the exposure time on their apical side, while
being nourished from their basolateral side. Direct exposure of
cells to airborne contaminants was initially achieved by growing
cells on collagen-coated membrane located on special construc-
tions (Chen et al., 1993) and more recently porous membranes
in transwell inserts (Knebel et al., 1998; Diabate et al., 2002;
Auftherheide et al., 2003).
The toxic effects of sulfuric acid aerosols on human airway
epithelial cells (Chen et al., 1993) and the effects of ozone on
cultures of primate bronchial epithelial cells (Jabbour et al.,
1998) or human bronchial cells (Mogel et al., 1998) have been
studied using cells grown on collagen-coated membranes. Toxic
effects of individual airborne chemicals such as ozone and nitro-
gen dioxide (Knebel et al., 1998) and complex mixtures such as
diesel motor exhaust (Knebel et al., 2002) and cigarette smoke
(Aufderheide et al., 2003) were studied using cultured human
lung cells on porous membranes permeable to culture media.
Direct exposure technique at the air/liquid interface offers a
reproducible contact between chemically and physically un-
modified airborne contaminants and target cells and technically
may reflect more closely inhalation exposure in vivo (Ritter et al.,
2001; Diabate et al., 2002; Knebel et al., 2002; Aufderheide
et al., 2003). A typical experimental set up for air/liquid exposure
requires appropriate exposure chambers. Standard tissue culture
incubators are used (Lang et al., 1998) or specific exposure
chambers (Aufderheide & Mohr, 2000) are designed for this
purpose.
CONCLUSION
Environmental and occupational exposure to chemical con-
taminants is a major health concern. While animals have been
traditionally used to study the toxic effects of chemicals and
inhaled contaminants, recent studies demonstrate that in vitro
methods may also have significant potential for studying respi-
ratory toxicity. Development, standardization, and validation of
reproducible in vitro test methods could play a significant role
in the study of respiratory toxicity and may lead to a better un-
derstanding of the interactions between chemical exposure and
toxic effects. The most appropriate cell systems with biotrans-
formation activities and cellular functions comparable to the
in vivo environment, such as primary cell cultures and human
cell-based assay systems, need to be implemented.
Although in vitro toxicology methods cannot exactly mimic
the biodynamics of the whole body, in vitro test systems in com-
bination with the knowledge of quantitative structure–activity
relationships (QSARs) and physiologically based toxicokinetic
(PBTK) models have a potential to be considered more broadly
for risk assessment of human chemical exposures. A systemic
approach for respiratory toxicity should commence with a com-
prehensive review of existing data, assessment of the physico-
chemical properties of test chemicals, and employment of any
structure–activity relationships (Lambre et al., 1996). A key
molecular structure may provide some readily available informa-
tion on toxicity prediction (Faustman & Omenn, 2001). Further,
the application of physiologically based toxicokinetic models
may provide a scientific basis for extrapolation of in vitro con-
centrations which produce cellular toxicity in vitro, to equivalent
in vivo dosages.
The study of the toxic effects of inhaled chemicals in vitro
requires the development of effective and reproducible tech-
niques for exposure of cell cultures to airborne contaminants.
In this article, in vitro methods developed for toxicity testing of
air contaminants have been reviewed and their advantages and
limitations in toxicity testing of inhaled chemicals have been
discussed. Direct exposure technique at the air/liquid interface
offers the possibility of exposing human target cells to physi-
cally and chemically unmodified airborne contaminants. During
the exposure time, continuous direct exposure can be achieved
by growing cells on porous membranes in transwell or snap-
well inserts. Direct exposure techniques may have the potential
to be applied extensively to study the toxic effects of airborne
contaminants and respiratory toxicity in vitro, as the exposure
pattern in vivo is more closely simulated by this method. Further,
development of appropriate in vitro sampling and exposure tech-
niques may provide an advanced technology for biomonitoring
of occupational and environmental airborne contaminants.
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